• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Mirion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    5/20/25 7:23:14 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials
    Get the next $MIR alert in real time by email
    mir-20250520
    FALSE000180998700018099872025-05-202025-05-20

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934
    Date of Report (date of earliest event reported): May 20, 2025
    Mirion Technologies, Inc.
    (Exact Name of Registrant as Specified in Its Charter)
    Delaware001-3935283-0974996
    (State or Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
    1218 Menlo Drive
    Atlanta, Georgia 30318
    (Address of Principal Executive Offices)
    (770) 432-2744
    (Registrant's telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange
    on which registered
    Class A common stock, $0.0001 par value per shareMIRNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 7.01. Regulation FD Disclosure.

    On May 20, 2025, Mirion Technologies, Inc. (the “Company”) announced its intent to offer $300.0 million aggregate principal amount of Convertible Senior Notes due 2030 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

    In the preliminary offering memorandum, dated May 20, 2025 relating to the proposed Offering, the Company disclosed that it intends to seek a term loan refinancing amendment (the “Refinancing Amendment”) to its existing Credit Agreement, dated as of October 20, 2021 (as amended by the Agreement and Amendment No. 1 to Credit Agreement, dated as of November 22, 2021, as further amended by Amendment No. 2 to Credit Agreement, dated as of June 23, 2023, as further modified by the Holdings Assumption Agreement, dated as of December 30, 2023, as further amended by Amendment No. 3 to Credit Agreement, dated as of May 22, 2024, as further amended by Amendment No. 4 to Credit Agreement, dated as of March 21, 2025, and as further amended, restated, supplemented or otherwise modified, refinanced or replaced from time to time, the “Credit Agreement”), by and among the Mirion IntermediateCo, Inc. (“Holdings”), Mirion Technologies (US Holdings), Inc. and Mirion Technologies (US), Inc. (together with Mirion Technologies (US Holdings), Inc., the “Borrowers”), the lending institutions from time to time party thereto, and Citibank, N.A as the Administrative Agent, the Collateral Agent and a Letter of Credit Issuer.

    If effectuated, the Refinancing Amendment will provide for a new tranche of term loans maturing in 2032 in an aggregate principal amount currently expected to be $450 million (the “Replacement Term Loans”). The proceeds of the Replacement Term Loans will be used, together with a portion of the net proceeds of the Offering, to refinance all outstanding term loans under the Company’s senior secured term loan immediately prior to the effectiveness of the Refinancing Amendment (including payment of fees and expenses in connection therewith). The Refinancing Amendment is also expected to provide for other changes to the Credit Agreement favorable to the Company and their subsidiaries, including greater flexibility for the payment of dividends, the making of dispositions and/or investments, and the incurrence of indebtedness and liens. The final terms, amount, interest and fees with respect to the Replacement Term Loans are subject to market conditions. There can be no assurance that the Company or its subsidiaries will consummate the Refinancing Amendment on the terms described or at all.

    The information in Item 7.01 on this Current Report on Form 8-K and the Exhibit attached hereto are being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall any such information or exhibits be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act.


    Item 8.01. Other Events.

    On May 20, 2025, the Company issued a press release announcing the proposed Offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    This Current Report on Form 8-K and the press release attached hereto do not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

    Cautionary Note Concerning Forward-Looking Statements

    Certain information contained or incorporated by reference in this Current Report on Form 8-K constitutes forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “seek,” “plan,” “project,” “target,” “looking ahead,” “look to,” “move into,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements represent the Company’s current beliefs, estimates and assumptions only as of the date of this press release and information contained in this press release should not be relied upon as representing the Company’s estimates as of any subsequent date. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to market risks, trends and conditions. These risks are not exhaustive. Further information on these and other risks that could affect the Company’s results is included in its filings with the Securities and Exchange Commission (“SEC”), including its Annual Report on Form 10-K for the year ended December 31, 2024, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 and the future reports



    that it may file from time to time with the SEC. The Company assumes no obligation to, and does not currently intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


    Item 9.01.     Financial Statements and Exhibits.
    (d) Exhibits
    EXHIBIT INDEX
    Exhibit
    Number
    Description
    99.1
    Press release issued by Mirion Technologies, Inc. dated May 20, 2025
    104Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)




    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: May 20, 2025

    Mirion Technologies, Inc.
    By:    /s/ Brian Schopfer    
    Name:    Brian Schopfer
    Title:    Chief Financial Officer

    Get the next $MIR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MIR

    DatePrice TargetRatingAnalyst
    12/19/2024$22.00Outperform
    Robert W. Baird
    9/26/2024$14.00Buy
    B. Riley Securities
    5/26/2023$11.00Buy
    Citigroup
    3/24/2022$13.00Market Outperform
    CJS Securities
    11/29/2021$14.00Buy
    Goldman Sachs
    10/25/2021$14.00Buy
    Citigroup
    More analyst ratings

    $MIR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mirion Technologies Announces Pricing of Upsized $350.0 Million Offering of 0.25% Convertible Senior Notes Due 2030

      Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced the pricing of $350.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2030 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The size of the Offering was increased from the previously announced $300.0 million aggregate principal amount of Notes. In connection with the Offering, Mirion granted the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first is

      5/20/25 11:56:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Technologies Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2030

      Mirion Technologies, Inc. ("Mirion") (NYSE:MIR), today announced its intent to offer $300.0 million aggregate principal amount of Convertible Senior Notes due 2030 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Mirion also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $45.0 million aggregate principal amount of Notes. The Offering is subject to market and other conditions, and there

      5/20/25 7:00:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    SEC Filings

    See more
    • SEC Form 144 filed by Mirion Technologies Inc.

      144 - Mirion Technologies, Inc. (0001809987) (Subject)

      5/21/25 6:33:37 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • SEC Form 144 filed by Mirion Technologies Inc.

      144 - Mirion Technologies, Inc. (0001809987) (Subject)

      5/21/25 4:20:49 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Mirion Technologies, Inc. (0001809987) (Filer)

      5/20/25 7:23:14 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Financials

    Live finance-specific insights

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance

       Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

      2/11/25 4:05:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Leadership Updates

    Live Leadership Updates

    See more
    • Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

      SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

      9/29/23 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Janus International Appoints David Vanevenhoven as Chief Accounting Officer

      Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

      2/21/23 7:00:00 AM ET
      $JBI
      $MIR
      Building Products
      Industrials
      Industrial Machinery/Components
    • Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

      Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

      10/3/22 8:00:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Robert W. Baird initiated coverage on Mirion Technologies with a new price target

      Robert W. Baird initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $22.00

      12/19/24 7:44:58 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • B. Riley Securities initiated coverage on Mirion Technologies with a new price target

      B. Riley Securities initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00

      9/26/24 7:38:28 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Citigroup resumed coverage on Mirion Technologies with a new price target

      Citigroup resumed coverage of Mirion Technologies with a rating of Buy and set a new price target of $11.00

      5/26/23 7:18:55 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mirion Technologies Inc.

      SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/14/24 1:28:33 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/13/24 6:42:31 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/6/24 6:59:38 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Kingsley Lawrence D was granted 7,977 shares, increasing direct ownership by 15% to 61,287 units (SEC Form 4)

      4/A - Mirion Technologies, Inc. (0001809987) (Issuer)

      5/16/25 5:18:59 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Executive Officer Logan Thomas D covered exercise/tax liability with 89,430 shares and was granted 213,234 shares, increasing direct ownership by 3% to 4,067,305 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      5/16/25 4:18:16 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Schopfer Brian covered exercise/tax liability with 29,149 shares and was granted 65,154 shares, increasing direct ownership by 4% to 919,432 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      5/16/25 4:17:32 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials